Insiders Arcutis Biotherapeutics, Inc.

Equities

Delayed Nasdaq Other stock markets 20:45:08 16/05/2024 BST			5-day change	1st Jan Change
9.16 ^USD	-0.87%		+14.71%	+184.83%

05-15	Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating	MT
05-15	Sector Update: Health Care Stocks Rise Pre-Bell Wednesday	MT

Arcutis Promotes Todd Tucker to Chief Human Resources Officer	03-11	CI
Arcutis Biotherapeutics, Inc. Announces Executive Changes	11-03	CI
Arcutis Biotherapeutics, Inc. Announces Executive Changes	27/09/23	CI
Aeglea BioTherapeutics Appoints Scott Burrows as CFO	05/09/23	MT
Arcutis Biotherapeutics Shares Extend Decline Following Friday Announcement CFO Scott Burrows Leaving to 'Pursue External Opportunity'	22/08/23	MT
Arcutis Biotherapeutics Names John Smither as Interim CFO	18/08/23	MT
Arcutis Biotherapeutics Chief Commercial Officer Ken Lock to Step Down; Ayisha Jeter Named Interim CCO	24/05/23	MT
Arcutis Biotherapeutics, Inc. Announces Executive Changes	24/05/23	CI
Insider Sell: Arcutis Biotherapeutics	10/04/23	MT
Insider Sell: Arcutis Biotherapeutics	21/02/23	MT
Insider Sell: Arcutis Biotherapeutics	06/10/22	MT
Arcutis Biotherapeutics, Inc. Announces Appointment of Neha Krishnamohan to Board of Directors	02/09/22	CI
Insider Sell: Arcutis Biotherapeutics	17/08/22	MT
Arcutis Biotherapeutics Inc. Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis	11/07/22	CI
Insider Sell: Arcutis Biotherapeutics	28/12/21	MT
Arcutis Biotherapeutics, Inc. Appoints Mas Matsuda as Corporate Secretary	16/12/21	CI
Arcutis Biotherapeutics, Inc. Announces Board Changes	07/09/21	CI
Insider Sell: Arcutis Biotherapeutics	03/09/21	MT
Arcutis Biotherapeutics, Inc. Announces Executive Changes	02/09/21	CI
Arcutis Biotherapeutics, Inc. Announces Executive Appointments	02/08/21	CI

No results for this search